PIVOTAL BIOVENTURE PARTNERS
Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. They invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. They invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. Their team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
PIVOTAL BIOVENTURE PARTNERS
Industry:
Biotechnology Venture Capital
Founded:
2017-01-04
Status:
Active
Contact:
415-697-1002
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Facebook Sharer GoDaddy Amazon SES Barracuda Networks KnowBe4
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-23 | Plexium | Pivotal bioVenture Partners investment in Series B - Plexium | 102 M USD |
| 2022-02-10 | Arkuda Therapeutics | Pivotal bioVenture Partners investment in Series B - Arkuda Therapeutics | 64 M USD |
| 2021-11-30 | SanReno Therapeutics | Pivotal bioVenture Partners investment in Funding Round - SanReno Therapeutics | 40 M USD |
| 2021-11-29 | HotSpot Therapeutics | Pivotal bioVenture Partners investment in Series C - HotSpot Therapeutics | 100 M USD |
| 2021-09-09 | Evommune | Pivotal bioVenture Partners investment in Series A - Evommune | 83 M USD |
| 2021-09-09 | Obsidian Therapeutics | Pivotal bioVenture Partners investment in Series B - Obsidian Therapeutics | 115 M USD |
| 2021-08-18 | Vigil Neuroscience | Pivotal bioVenture Partners investment in Series B - Vigil Neuroscience | 90 M USD |
| 2021-05-04 | Oculis | Pivotal bioVenture Partners investment in Series C - Oculis | 57 M USD |
| 2021-04-20 | Exscientia | Pivotal bioVenture Partners investment in Series D - Exscientia | 225 M USD |
| 2021-01-19 | Plexium | Pivotal bioVenture Partners investment in Series A - Plexium | 35 M USD |